Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
11th IEEE Conference of the Andean Council, ANDESCON 2022 ; 2022.
Article in English | Scopus | ID: covidwho-2213142

ABSTRACT

International organizations notes that the main weakness for innovation in Latin American countries is that their national research organizations only evaluate and stimulate pure academic personnel by publications and citations, forgetting those who work in industry, losing a vast potential in each country. Higher education institutions must increase the development and innovation if they want to contribute to the third mission, which means the economic development of a country, in addition to the traditional advanced education and research, to adapt to new realities for the knowledge-based economies. Commercial war, SARS COV-2, and energy crisis drive policymakers and university managers to rethink and redesign institutions. This work offers an approach to measure the research, development, and innovation capabilities of three telecommunications engineering careers in three Latin American universities in Mexico and Ecuador looking for to increasing capabilities when doing collaboration. Results confirm that the knowledge contribution in engineering is proportional to the number of supported engineering careers, even mapped to national and international rankings. Also is confirmed that research is related to the academic production, but development and innovation are more related to an effective relation to industry. © 2022 IEEE.

2.
IDS Bulletin ; 53(3):1-18, 2022.
Article in English | Scopus | ID: covidwho-1975552

ABSTRACT

This article situates, against the backdrop of the Covid-19 crisis and the many systemic inequalities the pandemic has highlighted, challenges and opportunities for researchers and commissioners of research. It provides examples from social science research of how researchers have demonstrated agility and adaptation during the pandemic in a range of contexts. It summarises findings and lessons around access and engagement, consent, ethics and incentives, and power and perspectives. It concludes that research supported by the Covid Collective is providing useful insights for doing research differently, which in turn provides real hope for research to help transform knowledge and transform lives. © 2022 The Authors. IDS Bulletin, Institute of Development Studies and Crown 2022.

3.
Routledge psychology in education ; 2022.
Article in English | APA PsycInfo | ID: covidwho-1733121

ABSTRACT

This book is an expansion and major updating of the highly successful Theories of Learning for the Workplace, first published in 2011. It offers fascinating overviews into some of the most important theories of learning and how they are practically applied to organisational or workplace learning. Each chapter is co-authored by an academic researcher and an expert in business or industry, providing practical case studies combined with a thorough analysis of theories and models of learning. Key figures in education, psychology, and cognitive science present a comprehensive range of conceptual perspectives on learning theory, offering a wealth of new insights to support innovative research directions and innovation in learning, training, and teaching for the upcoming post-Covid-19 decades. Containing overviews of theories from Argyris, Decuyper, Dochy & Segers, Engestrom, Ericsson, Kolb, Lave & Wenger, Mezirow, Raes & Boon, Schon, Senge, and Van den Bossche. Combining theory and practice, this book will be essential reading for all trainee and practising educational psychologists, organisational psychologists, researchers, and students in the field of lifelong learning, educational policy makers, students, researchers, and teachers in vocational and higher education. It will also be of interest to those involved in training trainers and teacher training. (PsycInfo Database Record (c) 2022 APA, all rights reserved)

4.
Asian J Psychiatr ; 63: 102750, 2021 Sep.
Article in English | MEDLINE | ID: covidwho-1309133

ABSTRACT

The COVID-19 pandemic impacted ongoing clinical trials globally resulting in the suspension, cancellation or transition to entirely remote implementation of studies. In India, the first countrywide lockdown was imposed in phases starting from March 2020 to June 2020, followed by a continued restriction on in-person activities including study procedures, which halted the ESSENCE (Enabling translation of Science to Service to ENhance Depression CarE) trial activities such as recruitment, consenting, baseline assessment, digital training orientation, face to face training and end-line assessment evaluation. This situation made it imperative to amend procedures in order to mitigate the risk and address safety requirements for participants and the research team. This paper summarizes the need, development and implementation of the protocols focused on risk reduction and safety enhancement with an objective to resume and continue the research activities while ensuring the safety of study participants and research staff. These protocols are comprised of guidelines and recommendations based on existing literature tailored according to different components in each arm of the trial such as guidelines for supervisors, travellers, training/recruitment venue safety procedures, individual safety procedures; and procedures to implement the study activities. These protocols can be adapted by researchers in other settings to conduct research trials during pandemics such as COVID-19.


Subject(s)
COVID-19 , Pandemics , Communicable Disease Control , Humans , India , Mental Health , Randomized Controlled Trials as Topic , Research Report , SARS-CoV-2
5.
Health Res Policy Syst ; 19(1): 10, 2021 Jan 21.
Article in English | MEDLINE | ID: covidwho-1043890

ABSTRACT

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has spread throughout more than 160 countries, infecting millions of people worldwide. To address this health emergency, countries have organized the flow of production and innovation to reduce the impact on health. This article shows the response of the Brazilian scientific community to meet the urgent needs of the public unified health system [SUS], aiming to guarantee universal access to an estimated population of 211 million. By December 2020, Brazil had recorded more than six million cases and approximately 175,000 deaths. METHODS: We collected data on research, development and innovation projects carried out by 114 public universities (plus Oswaldo Cruz Foundation [Fiocruz] and Butantan Institute), as reported on their websites. Additionally, we examined the studies on COVID-19 approved by the National Comission for Research Ethics, as well as those reported on the Ministry of Education website as of May 15, 2020. RESULTS: The 789 identified projects were classified according to research categories as follows: development and innovation (n = 280), other types of projects (n = 226), epidemiologic research (n = 211), and basic research on disease mechanisms (n = 72). Most proposals focused on the development and innovation of personal protective equipment, medical devices, diagnostic tests, medicines and vaccines, which were rapidly identified as research priorities by the scientific community. Some promising results have been observed from phase III vaccine trials, one of which is conducted in partnership with Oxford University and another of which is performed with Sinovac Biotech. Both trials involve thousands of volunteers in their Brazilian arms and include technology transfer agreements with Fiocruz and the Butantan Institute, respectively. These vaccines proved to be safe and effective and were immediately licensed for emergency use. The provision of doses for the public health system, and vaccination, started on January 17, 2021. CONCLUSIONS: The mobilized Brazilian scientific community has generated comprehensive research, development and innovation proposals to meet the most urgent needs. It is important to emphasize that this response was only possible due to decades of investment in research, development and innovation in Brazil. We need to reinforce and protect the Brazilian science, technology and innovation system from austerity policies that disregard health and knowledge as crucial investments for Brazilian society, in line with the constitutional right of universal health access and universal health coverage.


Subject(s)
Biomedical Research , COVID-19 , Delivery of Health Care , Pandemics , Public Health , Biomedical Research/economics , Brazil/epidemiology , Economics , Emergencies , Humans , Industry , Research Support as Topic , SARS-CoV-2 , Translational Research, Biomedical , Universities , Vaccination , Vaccines
SELECTION OF CITATIONS
SEARCH DETAIL